Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 26 for “"PIK3CA mutations"”.

  1. Detection of PIK3CA Mutations in Plasma Tumor DNA Circulating in Peripheral Blood of Breast Cancer Patients

    Tumor-specific mutations are used as genetic biomarkers for breast cancer diagnosis and prognosis. The detection and quantification of mutations in tumor DNA circulating in peripheral blood offers a non-invasive approach for measuring the presence of cancer in patients and for evaluating individual …

    jhu Repository record for Detection of PIK3CA Mutations in Plasma Tumor DNA Circulating in Peripheral Blood of Breast Cancer Patients (opens in a new tab)

  2. Defining the Roles of Oncogenic Pik3ca Mutations and Genetic Cooperation in Mouse Models of Breast Cancer

    Most human breast tumors have mutations in the growth factor/phosphatidylinositol 3’ kinase (PI3K) pathway. These can occur in genes coding for receptors, adaptor proteins, catalytic and regulatory subunits of PI3K, downstream kinases, or antagonistic tumor suppressors. While each genetic change …

    toronto-retro Repository record for Defining the Roles of Oncogenic Pik3ca Mutations and Genetic Cooperation in Mouse Models of Breast Cancer (opens in a new tab)

  3. Προσδιορισμός των μεταλλάξεων του BRAF γονιδίου στον καρκίνο του παχέος εντέρου

    … was identifiedin 40.3 % of cases, BRAF and PIK3CA in 8.8 % and10.5 % respectively. 29.8 % of patients responded to treatment.Median survival time was 14.3 months. Weight loss,fever, abdominal metastases, blood transfusion,hypoalbuminaimia, BRAF and PIK3CA mutations, CRP andDNA Index were …

    greece Repository record for Προσδιορισμός των μεταλλάξεων του BRAF γονιδίου στον καρκίνο του παχέος εντέρου (opens in a new tab)

  4. The role and expression of PCKiota in breast cancer

    … and expression of PKC&igr;, T47D and MCF7, have PIK3CA mutations E545K and HI047R respectively. To investigate the effects of PIK3CA mutations on PKC&igr;, stable MCF10A cells expressing E545K and H1047R mutations were generated using retroviral transduction. Western blot analysis showed that …

    ottawa-retro Repository record for The role and expression of PCKiota in breast cancer (opens in a new tab)

  5. Εκτίμηση της προβλεπτικής και προγνωστικής σημασίας του mTOR (mammalian Target Of Rapamycin) σε ασθενείς με καρκίνο του μαστού

    … nucleotide polymorphism (SNP) genotyping for PIK3CA mutations. These markers were correlated with selected patients and tumor characteristics, breast cancer immunohistochemical subtypes (classified by ER, PgR, HER2 and Ki67), disease-free survival (DFS) and overall survival (OS).concerning the …

    greece Repository record for Εκτίμηση της προβλεπτικής και προγνωστικής σημασίας του mTOR (mammalian Target Of Rapamycin) σε ασθενείς με καρκίνο του μαστού (opens in a new tab)

  6. Investigating The Role Of Pi3k Signaling In Cerebral Cavernous Malformation Pathogenesis

    … a monogenic disease caused by loss of function mutations in the CCM genes, the vast majority of CCMs arise in adults, often presenting as a single fast-growing lesion that culminates in hemorrhage or seizure. Though environmental differences explain the heterogeneity between individuals, why a …

    penn Repository record for Investigating The Role Of Pi3k Signaling In Cerebral Cavernous Malformation Pathogenesis (opens in a new tab)

  7. Circulating tumour DNA as a comprehensive multi-omic tool for profiling advanced prostate cancer

    … mCRPC molecular subtypes: activating AKT1/PIK3CA mutations, mismatch-repair deficiency (MMRd), and DNA repair defects in BRCA2/CDK12/ATM. Targeted ctDNA sequencing detected AKT1/PIK3CA mutations in 6% of mCRPC. Clonal prevalence, consistent temporal redetection across serial cfDNA, and …

    ubc Repository record for Circulating tumour DNA as a comprehensive multi-omic tool for profiling advanced prostate cancer (opens in a new tab) Download PDF for Circulating tumour DNA as a comprehensive multi-omic tool for profiling advanced prostate cancer (opens in a new tab)

  8. Basis For Targeting Met Activation Mediated Resistance to Pi3K Inhibition In Breast Cancer

    … early breast tumors, and showed that MET and PIK3CA are frequently co-amplified, and a high copy number of either gene is associated with poorer prognostic features and the triple negative disease.(2) Additionally, we determined the effect of MET-T1010I, MET-Y1253D and MET overexpression, …

    uthsc Repository record for Basis For Targeting Met Activation Mediated Resistance to Pi3K Inhibition In Breast Cancer (opens in a new tab)

  9. Global Analysis of the PI3K Signaling Pathway

    The human oncogene PIK3CA is frequently mutated in human cancers. Two hotspot mutations in PIK3CA, E545K and H1047R, have been shown to regulate widespread signaling events downstream of AKT, leading to increased cell proliferation, growth, survival, and motility. Although many studies have …

    jhu Repository record for Global Analysis of the PI3K Signaling Pathway (opens in a new tab)

  10. UTILITY OF PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS IN GASTROINTESTINAL CANCER

    … DIFFER SIGNIFICANTLY IN THE FREQUENCIES OF PIK3CA EXON 9 AND EXON 20 MUTATIONS, PTEN DELETION AND PTEN LOSS, WHILE CRC PATIENTS DIFFERED FOR PTEN LOSS. HIGH STUDY HETEROGENEITY WAS OBSERVED FOR ALL ABERRATIONS EXCEPT PIK3CA MUTATIONS. ANALYSIS OF TUMOURS FROM EAST ASIAN PATIENTS REVEALED …

    nus Repository record for UTILITY OF PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS IN GASTROINTESTINAL CANCER (opens in a new tab) Download file for UTILITY OF PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS IN GASTROINTESTINAL CANCER (opens in a new tab)

  11. Μοριακή ανάλυση πλακωδών καρκινωμάτων κεφαλής και τραχήλου

    … In addition, we performed mutation analysis for PIK3CA genes and high risk HPV DNA detection using PCR. Results: Mean time of follow-up was 16 months. Six patients were TNM Stage III, 15 patients IV (IVA or IVB), and one patient Stage II with bulky disease. During TPF-C, Grade 3 and 4 toxicities …

    greece Repository record for Μοριακή ανάλυση πλακωδών καρκινωμάτων κεφαλής και τραχήλου (opens in a new tab)

  12. The prognostic utility of perioperative blood-based liquid biopsy, inflammatory and tumour biomarkers in patients with non-metastatic breast cancer

    … quantified. Circulating tumour DNA (ctDNA) with PIK3CA gene mutation was detected using HRM PCR and Allele specific fluorescence probe-based PCR. Systemic inflammatory mediators and the tumour marker CA 15-3 were detected using ELISA kit. Results: In the cohort of 62 patients (age, median (IQR), …

    cork Repository record for The prognostic utility of perioperative blood-based liquid biopsy, inflammatory and tumour biomarkers in patients with non-metastatic breast cancer (opens in a new tab) Embargoed until 2029-12-31

  13. Genetic Analysis of Gata4 and RhoC, Modifiers of Her2/Neu Expression and Signaling, in a Mammary Tumor Context

    … breast cancer (BC), like HER2 amplification and PIK3CA mutations, have been well studied, less is known about mutations/alterations involved in tumor progression. Copy number aberration is very common in human BC. For example, approximately 50% of cases show loss of one copy of chromosome 8p, and …

    toronto-retro Repository record for Genetic Analysis of Gata4 and RhoC, Modifiers of Her2/Neu Expression and Signaling, in a Mammary Tumor Context (opens in a new tab)

  14. Impact of TP53 mutation on tumor microenvironment in HPV- HNSCC

    TP53 mutations are one of the most frequent genomic alterations in head and neck squamous cell carcinoma (HNSCC). Particularly, TP53 mutations are observed in HPV negative (HPV-) HNSCC patients and have a strong association with poor prognosis. However, the effects of TP53 mutations in tumor …

    jhu Repository record for Impact of TP53 mutation on tumor microenvironment in HPV- HNSCC (opens in a new tab)

  15. Modulation of Pi3K-Akt Pathway In Colorectal Cancer

    … cancers (CRC) through PTEN loss (PTENloss) and PIK3CA mutations (PIK3CAmut). Allosteric AKT inhibition with MK2206 monotherapy has been ineffective in CRC patients. We investigated the impact of MK2206 on pharmacodynamic (PD) markers and signaling pathways using reverse phase protein array …

    uthsc Repository record for Modulation of Pi3K-Akt Pathway In Colorectal Cancer (opens in a new tab)

  16. Μοριακοί δείκτες (προβλεπτικοί, προγνωστικοί παράγοντες) καρκίνου του στομάχου

    … 91 patients. EBV-positive tumors and tumors with mutations had higher intratumoral CD8 tumor-infiltrating lymphocyte density (p=0.009 and p=0.017, respectively). PIK3CA mutations were correlated with VEGFA overexpression (p=0.042), while KRAS mutations and HER2 expression were mutually exclusive …

    greece Repository record for Μοριακοί δείκτες (προβλεπτικοί, προγνωστικοί παράγοντες) καρκίνου του στομάχου (opens in a new tab)

  17. Tumour evolution over time, treatment and progression; exploring the molecular heterogeneity of oestrogen receptor positive breast cancer

    … letrozole. A PCR assay to detect 8 known PIK3CA mutations and assessment of PTEN status was performed at both the primary and secondary event in a second cohort of 120 patients with endocrine treated disease who relapsed with either recurrence, lymph node metastases, a new second primary …

    edinburgh Repository record for Tumour evolution over time, treatment and progression; exploring the molecular heterogeneity of oestrogen receptor positive breast cancer (opens in a new tab)

Page 1 of 2